|4Aug 13, 7:19 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Aug 13, 2013

Insider Transaction Report

Form 4
Period: 2013-08-12
Drake Lorin
VP, Sales and Marketing
Transactions
  • Sale

    Common Stock

    2013-08-12$23.69/sh1,000$23,69021,478 total

Documents

1 file
  • 4
    rrd388147.xmlPrimary